newsOcrelizumab has been recommended by the Scottish Medicines Consortium to…
10 December 2018 | By European Pharmaceutical Review
Ocrelizumab has been recommended by the Scottish Medicines Consortium to treat relapsing remitting multiple sclerosis (RRMS) in adults.